NDC 70771-1585-03 - NYSTATIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1585
- Requested NDC
- 70771-1585-03
- Package NDCs from labels
- 70771-1585-1, 70771-1585-3, 70771-1585-2, 70771-1585-03
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-12-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NYSTATIN - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-12-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1585-1 | NYSTATIN | 15 g in 1 BOTTLE, PLASTIC | POWDER | 15 | 5 | |
| 70771-1585-2 | NYSTATIN | 30 g in 1 BOTTLE, PLASTIC | POWDER | 30 | 5 | |
| 70771-1585-3 | NYSTATIN | 60 g in 1 BOTTLE, PLASTIC | POWDER | 60 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1585 | NYSTATIN POWDER [ZYDUS LIFESCIENCES LIMITED] | 5 | Current NDC, Legacy NDC, 3 package rows | 20241206_5d593aa9-f2e4-4adf-9f02-37832ffcb5b4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| nystatin | NYSTATIN | NuCare Pharmaceuticals,Inc. | 05cc72dd-8e05-bfb5-e063-6394a90a92f1 | 2026-08-19 | Adverse reactions | BDF1O1C72E |
| nystatin | NYSTATIN | Preferred Pharmaceuticals Inc. | 197e3046-3e58-4246-b260-f3995dce41a1 | 2026-08-05 | Adverse reactions | BDF1O1C72E |
| Nystatin and Triamcinolone Acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc., USA | dc886fb9-535c-4fd8-959a-f590a3bf3668 | 2026-08-04 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Preferred Pharmaceuticals Inc. | d92f67a7-dcae-41c0-9a35-dbafa2361170 | 2026-08-04 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | A-S Medication Solutions | 98bd8ccb-0c68-47b9-bcb4-c5d8217868d9 | 2026-07-24 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | PAI Holdings, LLC dba PAI Pharma | 28b4e26e-206a-4e8a-abfe-774b780e91c3 | 2026-07-21 | Adverse reactions | BDF1O1C72E |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 0bb31239-fb77-442a-a9ee-ba61b45e7e68 | 2026-07-14 | Adverse reactions | 646456 BDF1O1C72E |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 2d2c4f79-95b5-417e-b5c1-8fac1dd09ddc | 2026-07-09 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Preferred Pharmaceuticals Inc. | a97b4fa6-c1a7-4003-9321-3717eb640ea9 | 2026-07-06 | Adverse reactions | BDF1O1C72E |
| NYSTATIN | NYSTATIN | Kesin Pharma Corporation | 50737729-a4a4-e747-e063-6394a90adcc5 | 2026-06-30 | Adverse reactions | BDF1O1C72E |
| NYSTATIN | NYSTATIN | Bryant Ranch Prepack | 4f6f59fb-ae7d-48e5-b23e-a1d92160974f | 2026-05-11 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Torrent Pharmaceuticals Limited | 4949dea7-d2b9-4e0d-974a-39408fa174ba | 2026-05-08 | Adverse reactions | BDF1O1C72E |
| NYSTATIN | NYSTATIN | Genus Lifesciences Inc. | b25cbae5-eaf5-4501-b013-02c778ca4a4e | 2026-05-07 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Torrent Pharmaceuticals Limited | 559b5bd4-3564-4437-8d0a-fa3a972f8b83 | 2026-05-01 | Adverse reactions | BDF1O1C72E |
| Mycostatin | NYSTATIN | Direct_Rx | f1857ac0-806c-4a7e-e053-2995a90abbc0 | 2026-03-17 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | A-S Medication Solutions | f1b13a36-c349-4e26-a322-3ec02c610155 | 2026-03-16 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Chartwell RX, LLC | 9954118e-abe6-4388-98c9-4473d39b2e28 | 2026-03-05 | Adverse reactions | BDF1O1C72E |
| Nystatin and triamcinolone acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | NuCare Pharmaceuticals, Inc. | 4c122a83-a66a-15d6-e063-6294a90acfaa | 2026-03-02 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Cardinal Health 107, LLC | d59098da-1395-49fb-9fd6-947bbbeed56f | 2026-02-26 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Major Pharmaceuticals | 17b9e33d-da9c-467a-bbc4-9e257727f19a | 2026-02-23 | Adverse reactions | BDF1O1C72E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.